Arena Pharmaceuticals, Everest Medicines Enter into Development and Commercialization Partnership for Ralinepag and Etrasimod in China; Arena Receives Low Double-Digit Royalties, $12M Upfront Payment, And Is Eligible For $212M In Milestone Payments